Cite
HARVARD Citation
Miki, N. et al. (2021). A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan. JGH open. 5 (8), pp. 879-887. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Miki, N. et al. (2021). A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan. JGH open. 5 (8), pp. 879-887. [Online].